Phenex, Janssen to jointly develop autoimmune, inflammatory disorder therapeutics
The research deal will focus on the identification of the compounds targeting nuclear hormone receptor ROR?T and optimized for preclinical development. Advancement of the compounds resulting from the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.